Received Jun 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
Pharmacist called and reported that a consumer with Rheumatoid Arthritis had titers drawn for MMR-II and had no levels.; Information has been received from a pharmacist and referred to a female patient of unknown age. The patient's concurrent condition included rheumatoid arthritis. Concomitant medication included tofacitinib citrate (XELJANZ). The patient's medical history was not reported. On an unknown date, the patient vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis, the vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT). On an unknown date, the patient had titers drawn for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) and had no levels (Antibody test negative). The concomitant medication tofacitinib citrate (XELJANZ) was withheld by the physician so the patient could receive a booster dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II). The patient had sought medical attention. At the reporting time, the patient had not recovered from the event. The causal relationship between the event and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), sterile diluent (MERCK STERILE DILUENT) was not provided. Lot# is being requested and will be submitted if received.
Rheumatoid arthritis
XELJANZ; Sterile diluent
Test Name: Antibody titer test; Result Unstructured Data: no levels